Table 2 Weighted distribution of specific gravity-adjusted trace metals from 3rd study visit urine samples (μg/L) by preeclampsia case status (N = 383)
Metals | LOD | N (%) < LOD | Preeclamptic Median (IQR) or N detected (weighted %) | Non-preeclamptic Median (IQR) or N detected (weighted %) |
|---|---|---|---|---|
As | 0.30 | 0 (0) | 15.9 (6.05, 21.7) | 17.9 (9.59, 32.6) |
Ba | 0.10 | 4 (1.03) | 2.25 (0.93, 4.11) | 1.93 (0.98, 3.34) |
Cd | 0.06 | 214 (55.9) | 0.09 (0.06, 0.14) | 0.08 (0.04, 0.14) |
Cu | 2.50 | 32 (8.21) | 9.62 (8.77, 11.7) | 8.96 (6.73, 12.1) |
Hg | 0.05 | 32 (8.21) | 0.50 (0.24, 0.76) | 0.51 (0.27, 0.97) |
Mn | 0.08 | 6 (1.54) | 0.91 (0.53, 1.18) | 0.73 (0.51, 1.13) |
Mo | 0.30 | 0 (0) | 45.6 (36.2, 69.6) | 51.3 (37.1, 68.8) |
Ni | 0.80 | 54 (13.8) | 3.40 (1.86, 3.97) | 2.84 (1.88, 3.97) |
Pb | 0.10 | 92 (23.6) | 0.34 (0.16, 0.64) | 0.35 (0.15, 0.62) |
Se | 5.00 | 3 (0.08) | 36.3 (31.2, 46.0) | 37.0 (29.6, 45.6) |
Sn | 0.10 | 24 (6.15) | 0.47 (0.28, 0.98) | 0.63 (0.35, 1.22) |
Tl | 0.02 | 61 (15.6) | 0.13 (0.09, 0.16) | 0.13 (0.08, 0.18) |
Zn | 2.00 | 0 (0) | 294 (206, 398) | 242 (146, 364) |
Bea | 0.04 | 356 (91.3) | 3 (9.72) | 31 (9.61) |
Cra | 0.40 | 330 (84.6) | 7 (21.5) | 50 (13.2) |
Ua | 0.01 | 342 (87.7) | 4 (15.3) | 43 (11.3) |
Wa | 0.20 | 309 (79.2) | 4 (15.3) | 73 (19.5) |